1. IPO Structure and Objective

Pramodini Medicare Limited is planning to raise capital through an Initial Public Offering and has filed its DRHP for listing on NSE Emerge. The IPO includes a total of 58.51 lakh shares, out of which 53.5 lakh are fresh issue shares and 5 lakh are offered by promoters through Offer for Sale (OFS). The primary goal of this IPO is to raise funds for expansion, strengthen infrastructure, and support long-term business growth.

2. Fundraising Plan and Utilization

The company is expected to raise around ₹45.1 crore through the fresh issue. A major portion of these funds will be invested in acquiring advanced medical equipment such as diagnostic machines, which will enhance the company’s service quality and help expand its operational capacity. The remaining funds will be allocated toward general corporate purposes and potential inorganic growth opportunities like acquisitions, ensuring future scalability.

3. Business Model and Operational Strategy

Pramodini Medicare Limited operates in the diagnostic services segment, providing radiology, laboratory testing, and nuclear medicine services. Its business model is diversified, as it works through public-private partnerships (PPP) with government hospitals, strategic agreements with public sector units (PSUs), and also runs independent private diagnostic centers. This multi-channel approach helps the company maintain stable and consistent revenue streams.

4. Financial Performance and Growth Trends

The company has demonstrated strong financial growth in recent periods. For the nine months ending December 2025, it reported revenue of approximately ₹44.4 crore and a net profit of ₹12.5 crore, reflecting nearly 74% growth compared to the previous financial year. This performance indicates efficient operations, strong demand for its services, and its ability to generate healthy margins in a competitive market.

5. Investment Opportunity for Investors

This IPO offers investors an opportunity to participate in India’s rapidly growing healthcare and diagnostics sector. Increasing health awareness, rising demand for diagnostic services, and technological advancements are driving sector growth. As an SME IPO, it may offer high growth potential and attractive returns for early investors if the company successfully executes its expansion plans.

6. Risks and Challenges

Despite the growth prospects, the investment carries certain risks. The diagnostic business requires high capital expenditure, especially for setting up new centers and purchasing expensive medical equipment. Maintenance costs, regulatory compliance, and competition from established players can also impact profitability. Additionally, continuous technological upgrades are necessary to stay competitive, which may increase operational costs.